Novel synthetic derivatives of cinnamic and p-coumaric acids with antiproliferative effect on breast MCF-7 tumor cells

Nat Prod Res. 2023 Nov-Dec;37(24):4210-4220. doi: 10.1080/14786419.2023.2177992. Epub 2023 Feb 17.

Abstract

p-Coumaric acid is derived from cinnamic acid and is one of the major compounds in the Brazilian green propolis extract. Studies have shown that both p-coumaric acid and cinnamic acid have promising antiproliferative effects. In this context, aiming to increase the complexity of these active natural products and their activities, we performed coupling reactions with propargylamine and benzylamine, as well as with threonine, phenylalanine and lysine amino acids, aiming to enhance their antiproliferative effects towards the hormone-dependent breast cancer MCF-7 cells. Overall, the p-coumaric acid coupling with L-threonine amino acid (compound 15) had the best selectivity index (SI = 5.1), with half-maximal inhibitory concentration of 39.6 ± 1 μM, showing a high selectivity against hormone-dependent breast cancer cell lines MCF-7 and low cytotoxicity against the normal breast cell lines MCF-10A. Thus, this new natural product derivative may represent a prototype for the future development of antiproliferative agents, especially against hormone-dependent breast cancer.

Keywords: Amino acid derivatives; green propolis; hormone-dependent breast cancer; phenolic compounds.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Breast Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Cell Proliferation
  • Coumaric Acids / pharmacology
  • Female
  • Hormones / pharmacology
  • Hormones / therapeutic use
  • Humans
  • MCF-7 Cells

Substances

  • cinnamic acid
  • p-coumaric acid
  • Coumaric Acids
  • Antineoplastic Agents
  • Hormones